Chamini Perera

Dr. Chamini Perera

1. South Western Sydney Clinical School, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia
+1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
RSRohit Sarkar
Rohit Sarkar
ZXZhihong Xu
Zhihong Xu
CPChamini Perera
Chamini Perera
MAMinoti V. Apte
Minoti V. Apte

18 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CPChamini Perera
Chamini Perera
Marco FalascaMarco Falasca
Marco Falasca
SCSuresh T. Chari
Suresh T. Chari
JGJerry R. Greenfield
Jerry R. Greenfield
ZXZhihong Xu
Zhihong Xu
MAMinoti Vivek Apte
Minoti Vivek Apte
Pancreatic ductal adenocarcinoma (PDAC) is a devastating condition characterised by vague symptomatology and delayed diagnosis. About 30% of PDAC patients report a history of new onset diabetes, usually diagnosed within 3 years prior to the diagnosis of cancer. Thus, new onset diabetes, which is also known as pancreatic cancer-related diabetes (PCRD), could be a harbinger of PDAC. Diabetes is driven by progressive β cell loss/dysfunction and insulin resistance, two key features that are also found in PCRD. Experimental studies suggest that PDAC cell-derived exosomes carry factors that are detrimental to β cell function and insulin sensitivity. However, the role of stromal cells, particularly pancreatic stellate cells (PSCs), in the pathogenesis of PCRD is not known. PSCs are present around the earliest neoplastic lesions and around islets. Given that PSCs interact closely with cancer cells to drive cancer progression, it is possible that exosomal cargo from both cancer cells and PSCs plays a role in modulating β cell function and peripheral insulin resistance. Identification of such mediators may help elucidate the mechanisms of PCRD and aid early detection of PDAC. This paper discusses the concept of a novel role of PSCs in the pathogenesis of PCRD.

Verified
Journal Article
Open access
PDF file
HBHelen Binang
Helen Binang
CPChamini Perera
Chamini Perera
MAMinoti Vivek Apte
Minoti Vivek Apte
One of the most common and deadly types of pancreatic cancer (PC) is pancreatic ductal adenocarcinoma (PDAC), with most patients succumbing to the disease within one year of diagnosis. Current detection strategies do not address asymptomatic PC; therefore, patients are diagnosed at an advanced stage when curative treatment is often no longer possible. In order to detect PC in asymptomatic patients earlier, the risk factors that could serve as reliable markers need to be examined. Diabetic mellitus (DM) is a significant risk factor for this malignancy and can be both a cause and consequence of PC. Typically, DM caused by PC is known as new-onset, pancreatogenic, pancreoprivic, or pancreatic cancer-related diabetes (PCRD). Although PCRD is quite distinct from type 2 DM (T2DM), there are currently no biomarkers that differentiate PCRD from T2DM. To identify such biomarkers, a better understanding of the mechanisms mediating PCRD is essential. To this end, there has been a growing research interest in recent years to elucidate the role of tumour-derived exosomes and their cargo in the pathogenesis of PCRD. Exosomes derived from tumours can be recognized for their specificity because they reflect the characteristics of their parent cells and are important in intercellular communication. Their cargo consists of proteins, lipids, and nucleic acids, which can be transferred to and alter the behaviour of recipient cells. This review provides a concise overview of current knowledge regarding tumour-derived exosomes and their cargo in PCRD and discusses the potential areas worthy of further study.

16 April 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
DHDavid Housley
David Housley
JPJeremy L. Pinyon
Jeremy L. Pinyon
GJGeorg von Jonquieres
Georg von Jonquieres
CPChamini Perera
Chamini Perera
MSMichael Smout
Michael Smout
GHGary Housley
Gary Housley
Scorpion venoms are a rich source of bioactive molecules, but characterisation of toxin peptides affecting cytosolic Ca2+, central to cell signalling and cell death, is limited. We undertook a functional screening of the venom of the Australian scorpion Hormurus waigiensis to determine the breadth of Ca2+ mobilisation. A human embryonic kidney (HEK293) cell line stably expressing the genetically encoded Ca2+ reporter GCaMP5G and the rabbit type 1 ryanodine receptor (RyR1) was developed as a biosensor. Size-exclusion Fast Protein Liquid Chromatography separated the venom into 53 fractions, constituting 12 chromatographic peaks. Liquid chromatography mass spectroscopy identified 182 distinct molecules with 3 to 63 components per peak. The molecular weights varied from 258 Da—13.6 kDa, with 53% under 1 kDa. The majority of the venom chromatographic peaks (tested as six venom pools) were found to reversibly modulate cell monolayer bioimpedance, detected using the xCELLigence platform (ACEA Biosciences). Confocal Ca2+ imaging showed 9/14 peak samples, with molecules spanning the molecular size range, increased cytosolic Ca2+ mobilization. H. waigiensis venom Ca2+ activity was correlated with changes in bio-impedance, reflecting multi-modal toxin actions on cell physiology across the venom proteome.

26 February 2026 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Open access
RSRohit Sarkar
Rohit Sarkar
PWPatrick Wu
Patrick Wu
HBHelen Binang
Helen Binang
PRParvathy Rajan
Parvathy Rajan
SHS.M. Zahid Hosen
S.M. Zahid Hosen
CPChamini Perera
Chamini Perera
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy often accompanied by pancreatic cancer related diabetes (PCRD), a paraneoplastic condition characterised by early metabolic dysfunction. Emerging evidence suggests that factors carried by exosomes, small extracellular vesicles secreted by tumour cells and pancreatic stellate cells (PSCs), play a pivotal role in mediating intercellular communication and metabolic reprogramming associated with PCRD. While protein and RNA contents of exosomes have been studied as potential mediators of PCRD, their lipid cargo remains underexplored. In this study, we employed targeted liquid chromatography triple quadrupole mass spectrometry (LC-QQQ-MS) to profile lipids in exosomes derived from mouse PSCs (PSC-Ex), pancreatic cancer KPC cells (KPC-Ex), and their co-cultures (PSC + KPC-Ex), along with their parent cell pellets. A total of 451 lipid species were identified, encompassing phospholipids, sphingolipids, triglycerides, and cholesteryl esters. Principal component analysis revealed distinct lipid signatures between exosomes and their parent cells, indicating selective lipid loading. Notably, PSC-Ex were enriched in lysophosphatidylcholines (e.g., LPC 16:0, LPC 22:5), which have been implicated in enhancing insulin secretion and modulating inflammation. Conversely, KPC-Ex exhibited higher levels of ganglioside GM3(d18:1_24:0), sphingomyelin SM(d18:1_16:1), and phosphatidylethanolamine PE(16:0_20:3), lipids associated with insulin receptor inhibition and membrane remodelling in cancer. Co-culture exosomes demonstrated a shift toward glycosphingolipids, with an enrichment of lactosylceramide (Hex2Cer(d18:1_16:0), a lipid linked to insulin resistance and tumour progression. These findings suggest that exosomal lipid composition is modulated by tumour-stromal interactions and may contribute to systemic glucose dysregulation in PDAC. Identifying specific bioactive lipids within exosomes offers potential for developing biomarkers for early detection of PCRD and understanding the metabolic crosstalk in pancreatic cancer.

13 October 2026 in Pancreatology
Verified
Journal Article
Open access
RSRohit Sarkar
Rohit Sarkar
CPChamini Perera
Chamini Perera
MHMd J. Hossain
Md J. Hossain
VTVictoria Tyma
Victoria Tyma
DPDinuki Perera
Dinuki Perera
MAMinoti Vivek Apte
Minoti Vivek Apte
Diabetes is a known risk factor, and a distinct form termed pancreatic cancer-related diabetes (PCRD) often precedes the diagnosis of cancer by 3-5 years, offering a potential window for intervention. We hypothesised that interactions between stromal pancreatic stellate cells (PSCs) and cancer cells trigger secretion of exosomal factors that impair islet function and insulin signalling, contributing to PCRD pathogenesis. KC (KrasLSL-G12D/+; Pdx1-Cre) mice were fed a high-fructose diet (HFrD) or control diet for 16 weeks. Exosomes were isolated from monocultures and co-cultures of cancer/PanIN cells with PSCs, characterised by nanoparticle tracking analysis and transmission electron microscopy, and incubated with mouse β-cells (MIN6) and peripheral cells (hepatocytes, adipocytes, skeletal myocytes). Effects on insulin secretion and insulin-signalling factors were examined. Exosomal glucose-6-phosphate dehydrogenase (G6PD) expression was modulated by siRNA to assess functional impact. HFrD induced marked glucose intolerance in KC mice and was accompanied by enhanced PSC activation, macrophage infiltration, inflammation, and accelerated PanIN progression. Exosomes from PSCs, cancer cells, and co-cultures displayed typical morphology and marker expression and were efficiently internalised by β-cells and hepatocytes. Functionally, exosomes significantly impaired glucose-stimulated insulin secretion in mouse and human β-cells without altering insulin content. In hepatocytes, PSC-, cancer-, and co-culture-derived exosomes reduced key insulin-signalling components, including IR, IRS, AKT, FOXO1 and GLUT2, and inhibited glucose uptake. Silencing exosomal G6PD partially restored hepatocyte insulin signalling. This study identifies a potential contributor to PCRD and suggests a possible mechanistic role for exosomal G6PD in impaired insulin signalling associated with PCRD.